FDA recall D-1388-2012

Abbott Laboratories · Class II · drug

Product

Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial carton, Rx only, Manufactured by Hospira, Inc. For Abbott Laboratories, North Chicago, IL 60064, USA, NDC 0074-1658-05

Reason for recall

CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2012-05-14
Report date
2012-06-27
Termination date
2012-12-03
Voluntary/Mandated
Voluntary: Firm initiated
Location
Abbott Park, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1388-2012